Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. A comparison between the efficacy of intralesional injection of 2% Zinc Sulfate solution with Glucantime in the treatment of acute old world cutaneous Leishmaniasis: A randomized, double-blind, controlled clinical trial

AR Firooz; AR Khatami; A Khamesipour; M Nassiri Kashani; MA Nilforoushzadeh; F Behnia; HR Pazoki Toroudi; Y Dowlati

Volume 7, Issue 4 , 2004, , Pages 209-218

Abstract
  Background: Several treatment modalities have been used for cutaneous leishmaniasis (CL) with various results. In vitro and in vivo studies have shown inhibitory effects of zinc sulfate (ZnSO4) on Leishmania parasites. Objective: To compare the efficacy of intralesional injections of 2% ZnSO4 solution ...  Read More

2. Efficacy of Paromomycin ointment prepared in Iran (Paromo-U) against cutaneous Leishmaniasis caused by Leishmania major in mouse model

M Mohebali; P Yaghoobi; B Hooshmand; A Khamesipour

Volume 7, Issue 2 , 2004, , Pages 88-94

Abstract
  Background: Considering the difficulties, adverse effects and unsuitable response to commonly used drugs; it is essential to find an alternative, particularly local treatment for cutaneous leishmaniasis (CL). Objective: Determination of efficacy of topical paromomycin (Paromo-U ointment) against CL caused ...  Read More

3. Interferon-γ production and Leishmanin skin test in non-healing cutaneous Leishmaniasis compared with healed individuals

H Mortazavi; A Khamesipour; Z Hallaji; H Bakhshi; A Miramin Mohammadi

Volume 5, Issue 4 , 2002, , Pages 3-9

Abstract
  Background: Cutaneous leishmaniasis (CL) is a self-healing disease, but due to unknown causes, a few cases of CL could get a chronic or non-healing course. These cases of chronic and recurrent leishmaniasis are defined as non-healing. Objectives: Comparison of the production of interferon-γ (IFN-γ) ...  Read More

4. Identification of Leishmania species using monoclonal antibodies in Isfahan

SH Hejazi; P Nasrifar; S Jamali; AA Jahangir Nezhad; A Khamesipour

Volume 4, Issue 1 , 2000, , Pages 7-11

Abstract
  Background: Isfahan is one of the major foci of cutaneous leishmaniasis in Iran. According to the epidemiological studies, both urban and rural forms have been reported in Isfahan. Accurate identification and characterization of Leishmania is essential for the control of the disease. Several different ...  Read More

5. Treatment of cutaneous Leishmaniasis with 5% Garlic cream: A randomized, double-blind study

AR Gholami; A Khamesipour; A Momeni; T Ghazanfari; MA Nilforoush Zadeh; Z Darajeh; Y Dowlati

Volume 3, Issue 3 , 2000, , Pages 2-6

Abstract
  Background: Cutaneous leishmaniasis (CL) is a protozoan disease of the skin caused by a wide range of italic species. The disease is endemic in many countries. It has been recognized as a major public health problem in Iran. Many treatments have been suggested for it but none of them was fully effective. ...  Read More

6. Comparison of different antigens for Leishmanin skin test in patients with cutaneous Leishmaniasis

A Momeni; A Khamesipour; A Bagher Zadeh; M Amin Javaheri

Volume 3, Issue 1 , 1999, , Pages 24-30

Abstract
  Background: Cell-mediated immunity (CMI) plays an important role in resistance against leishmaniasis. Leishmanin test (Montenegro skin test) is a method in evaluation of immune system reaction against cutaneous leishmaniasis. The TDR/WHO reference Leishmanin produced by the Pasteur Institute of Iran ...  Read More